To make essential drugs available to needy patients in poor countries, those countries need to take down their trade barriers.

How do regulatory barriers restrict access medication in developing countries?

The global system for public health donations has a crippling accountability problem.

A new book offers an engaging account of the burgeoning field of gerontology, the study of aging and of medicinal tools to block its unwanted effects, and makes clear that a few adventurous researchers are still searching for the elusive fountain of youth.

Developing cannabis into aneffective prescription medication can be a goal within reach. But it will take a federal government that is truly open to the research that it claims to value.

Medicines have to pass through a rigorous series of clinical trials to prove their efficacy and safety; by bypassing systems that are in place, the manufacturers of counterfeit medicines are not only illegally profiting from others' endeavors--they are also putting patients' lives at risk.

Eradicating corruption from the health sector through the removal of tariffs is vital.

Health care is taking up more and more of government budgets globally, and corruption is probably rising faster in health care than almost any other sector.